Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants

Baron, John A.; Berndt, Sonja I.; Brenner, Hermann; Butterbach, Katja; Caan, Bette J.; Campbell, Peter T.; Carlson, Christopher S.; Casey, Graham; Chang-Claude, Jenny; Chanock, Stephen J.; Cotterchio, Michelle; Duggan, David; Figueiredo, Jane C.; Fuchs, Charles S.; Giovannucci, Edward L.; Gong, Jian; Haile, Robert W.; Harrison, Tabitha A.; Hayes, Richard B.; Hoffmeister, Michael; Hopper, John L.; Hudson, Thomas J.; Hutter, Carolyn M.; Jacobs, Eric J.; Jenkins, Mark A.; Jiao, Shuo; Lemire, Mathieu; Lin, Yi; Lindor, Noralane M.; Nan, Hongmei; Ulrich, Cornelia M.; White, Emily

Association of Aspirin and NSAID Use With Risk of Colorectal Cancer According to Genetic Variants

Abstract

Use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is associated with lower risk of colorectal cancer. Prior studies examining a potential differential relationship of aspirin and NSAIDs with colorectal cancer risk according to genetic factors have been limited to analyses of candidate genes or pathways

Similar works

Full text

Open in the Core reader

Download PDF

Available Versions

Carolina Digital Repository

cdr.lib.unc.edu:g732dh19f

Last time updated on 24/11/2020